SUBSCRIBE
SUBSCRIBE
News   Business

Oxygen Biotherapeutics, Inc. Names New Chief Financial Officer

September 25, 2008 | 
1 min read
COSTA MESA, Calif.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (OTCBB:OXBO) today announced the appointment of Charles H. Seeman as the company’s chief financial officer and executive vice president finance and administration.
People
Tenax Therapeutics
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Gilead guts Arcellx team as BioNTech plant closures will wipe out 1,860 jobs
May 6, 2026
 · 
49 min read
 · 
BioSpace Editorial Staff
Podcast
Pfizer, Lilly, more report Q1, FDA names acting CBER director and an ALS awakening
May 6, 2026
 · 
1 min read
 · 
Heather McKenzie
Businessman on Red and white sailing boat in the ocean, Leadership and Business concept, Creative idea, Future success. Paper art vector and illustration. The sky after Raining and big strom.
Earnings
Pfizer is a 2029 story but Q126 lays foundation for growth
May 5, 2026
 · 
3 min read
 · 
Annalee Armstrong
Factory closed with disappointed worker doodle cartoon illustration. Industrial shutdown. Layoff in manufacturing plant closure 2D flat character isolated on white. Doodleart hand-drawn drawing
Layoffs
BioNTech moves to close multiple manufacturing plants, affecting 1,860 jobs
May 5, 2026
 · 
2 min read
 · 
Nick Paul Taylor